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1684-1182/Copyright ª 2014, TaiwanMinigenomes (MGs) are complementary DNAs of the synthetic analogs of genomic RNA. MGs are
widely used to study the life cycle of the Paramyxoviridae family of viruses. MG-based studies
have provided valuable insights into the mechanisms of viral replication and transcription in
this family, including the roles of viral proteins, the location and boundaries of the cis-acting
elements, the functional domains of trans-acting proteins, techniques for the measurement of
neutralizing antibody, virusehost interactions, and the structure and function of viral RNA.
This article provides a brief overview of the principle and application of MG technology in
studies involving members of the Paramyxoviridae family. The advantages, potential limita-
tions, and future scope of MG technology are also discussed.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
The minigenome (MG) system, also known as minireplicon
or MG technology, is considered as a complementary and
powerful tool for exploring the life cycle of a virus during
infection. The Paramyxoviridae family includes viruses withal Disease Control Center,
t, Chaoyang Region, Beijing
(X. Cai).
.02.008
Society of Microbiology. Publisheda genome consisting of negative-sense, nonsegmented
single-stranded RNA, some of which cause serious diseases
in humans and animals.1,2 Increasing numbers of MG sys-
tems specific to this family have been successfully con-
structed. In comparison with traditional experimental
approaches such as single proteineprotein interaction
experiment, these dynamic MG-associated studies have
expanded our knowledge for viruses belonging to this
family. In this review, we will provide a brief overview of
the design and execution of an MG assay as well as the
related applications in studies involving members of the
Paramyxoviridae family. The advantages, potentialby Elsevier Taiwan LLC. All rights reserved.
124 J. Su et al.limitations, as well as use of MGs in combination with other
experimental approaches are also emphasized.Key elements of an MG construct
Understanding the essential elements for MG assay is a key
step to designing a complete and efficient MG experiment.
Fig. 1 shows a schematic of an MG assay and its replication
and translation process. The MG plasmid DNA contains a
promoter for T7 polymerase (T7) and for RNA polymerases I
and II (pol I and pol II, respectively), a viral 50-untranslated
region (50-UTR), reporter gene, viral 30-UTR, and a termi-
nator for T7, pol I, and pol II (Fig. 1A).
More specifically, an MG construct is an artificial DNA
sequence consisting of a reporter gene flanked by the
corresponding viral 50- and 30-UTRs. The UTRs contain all
regulatory elements needed for encapsidation, transcrip-
tion, replication, and packaging of the viral genome into a
progeny virus.3,4 During construction, an MG complemen-
tary DNA (cDNA) is inserted in the antisense orientation
downstream of the associated promoter sequence to avoid
its direct transcription into messenger RNA (mRNA) by RNA
polymerase. The viral open reading frame itself is replacedFigure 1. A schematic of a minigenome (MG) and its replication a
promoter for T7 polymerase (T7 pol), RNA pol I, and RNA pol II; a vir
30-UTR, and a terminator (for T7, pol I, and pol II). (B) In the first ste
plasmid DNAs are transcribed by the corresponding RNA pol to gene
into an encapsidated MG RNA, in the presence of the correspondin
example, morbillivirus phosphoprotein (P) and large pol (L) protein
negative-sense encapsidated MG RNA as a template. The positive st
as a key step in viral replication. Both positive and negative RNA s
Step 3, the encapsidated negative RNA strand is transcribed into sh
complete 50- and 30-UTR. (E) Finally, the transcribed mRNA is trans
CAT Z chloramphenicol acetyltransferase.by a reporter gene, which is an artificial DNA sequence.
Genes encoding chloramphenicol acetyltransferase (CAT),
firefly luciferase, or green fluorescent protein are often
used as reporters in MG systems.5,6 Of these, luciferase has
a 100-fold greater sensitivity than that achieved with the
CAT assay, as 1020 mol of luciferase can be measured
under optimal conditions.7
To generate an anti-MG RNA, MG constructs have to be
inserted in the antisense orientation between RNA poly-
merase promoter and terminator sequences (Fig. 1A). Pre-
viously, the bacteriophage T7 pol promoter8 and eukaryotic
RNA polymerase promoter9 had been widely used in MG-
based studies. In addition, the hepatitis d ribozyme (HDd)
sequence has also been placed between the viral UTR and
the T7 terminator sequence (Fig. 1A). The HDd catalyzes
self-cleavage of a phosphodiester bond between the re-
porter gene and the HDd sequence, creating a viral RNA
strand-like negative RNA transcript.10
Exogenous bacteriophage T7 pol has also been used to
transcribe the MG plasmid into an MG RNA from the T7
promoter in a T7-based system. Furthermore, the approach
to generating T7 pol depends on the research purpose and
availability of experimental material, among other factors
and affects the level of target gene expression driven by and translation processes. (A) The MG plasmid DNA. It contains a
al 50-untranslated region (50-UTR), a reporter gene (RG), a viral
p, after transfection of the plasmid DNA into recipient cells, the
rate a negative-sense (e) MG RNA, which is then encapsidated
g nucleocapsid protein (N). (C) In Step 2, with the help of, for
s, an encapsidated sense (þ) anti-MG RNA is produced using the
rand is in turn used as template to generate the negative strand
trands contain the full-length 50- and 30-UTR sequences. (D) In
orter sense MG transcripts [messenger RNA (mRNA)] lacking the
lated by host-cell machinery to produce the reporter proteins.
Minigenome technology 125T7-based system.11 Interestingly, when three G residues
precede the T7 promoter sequence, the transcription effi-
ciency of T7 pol is increased, and it has been reported that
placing an encephalomyocarditis virus internal ribosome
entry site sequence between the T7 promoter and the
inserted open reading frame enhances protein
expression.12
The pol I-based system is more attractive than the T7-
based system in the development of some MG systems,13
because it does not require exogenous T7 pol and ribo-
zyme cleavage. Transcription of the MG plasmid is driven by
RNA pol I that is present in the nucleolus of all eukaryotic
cells. This system is therefore ideally suitable for studying
viruses, such as influenza virus, which are transcribed in the
nucleus. The many advantages of the pol I system over the
T7 pol system have been reviewed previously.14 Recently,
the Vero cell line-derived pol I promoter was verified to be
more efficient than that of human pol I in rescuing re-
combinant influenza A virus using the Vero cell line.15,16
These results indicated that the high efficiency of the
eukaryotic RNA pol I promoter may be tightly related to
host-cell specificity. However, the cytomegalovirus pro-
moter could not rescue a Sendai virus (SeV) MG, whereas a
T7-based system could.13 In short, the T7-based system has
a wider application compared with the eukaryotic RNA pol
system; this may be due to the lack of cell specificity of the
T7-based system, and the cell or virus specificity of the
eukaryotic RNA pol.Reporter gene expression
A successful MG experiment is characterized by MG reporter
gene expression. The MG RNA mimics the process of viral
RNA replication, transcription, and translation. Therefore,
the first step in forming a ribonucleoprotein (RNP) complex
in an MG assay is encapsidation of the artificial antisense
RNA by N protein into an RNase-resistant nucleocapsid
(encapsidated genomic RNA; Fig. 1B). The (e) MG-based
RNP (M-RNP) complex of the Paramyxoviridae family has
previously been demonstrated to function as a template for
MG RNA transcription and replication, whereas the naked
RNA does not.17,18 The L protein then uses (e) M-RNP (eRNP
analogy) as a template to generate MG mRNA, which is
capped at the 50 end and also contains a poly(A) tail at the
30 end (Fig. 1D). Recipient cell machinery can then trans-
late this into a reporter protein (Fig. 1E), which can then be
used to verify a functional MG system.
The N, P, and L proteins are termed helper proteins. In
the MG system, these proteins are generated from host
cells infected by homologous viruses and/or transfected
with recombinant plasmids harboring these helper protein
genes. Virus-free plasmid-based MG assays are much safer
and controlled. More important, this approach eliminates
the potential danger of using live viruses, and thus is a
useful method for studying the mechanism associated with
viral transcription and replication in a dynamic state. In
addition, the ratio of the helper plasmids is critical in
determining the efficiency of MG reporter gene expression.
The optimum ratios, as well as the amounts of helper
plasmids and MG constructs, should be adjusted based on
the expression level of the reporter gene. For example, theamount of the plasmid encoding RNA-dependent RNA pol
(RdRp) should be less than that of the other helper plas-
mids.8 By contrast, the efficiency of the MG system also
depends on both proteineprotein and RNAeprotein in-
teractions. It is obvious that the plasmid-based approach
has the disadvantage of requiring transfection of more than
four types of plasmids into each recipient cell, which can
limit the efficiency of transfection and target gene
expression.
Applications of MG technology
Roles of viral protein
Understanding the roles of viral proteins will greatly
contribute to the understanding of the life cycle of the
Paramyxoviridae family. The MG technology has rapidly
developed into a novel tool for studying viral proteins
involved in viral replication and transcription. The roles of
structural and nonstructural proteins are discussed in the
following sections.
Structural protein
Viral structural proteins are structural components of a
mature virus. The N, P, and L proteins and the matrix (M)
protein are the main structural proteins associated with
viral RNA replication, transcription, and translation. The N
protein serves several functions in the viral life cycle,
including encapsidation of the genomic RNA, association
with the PeL polymerase during replication and transcrip-
tion, and, most likely, interaction with the M protein during
virus assembly.
The N protein has been intensively studied with MG
technology. The soluble N protein of human respiratory
syncytial virus (hRSV) is required for hRSV MG replication,19
and increased expression of N protein did not alter the
balance between MG RNA transcription and replication.
Moreover, optimal levels of cytoplasmic N protein are
required for efficient replication, whereas an excessive
amount may be deleterious.20 In addition, two regions of
the N protein, a central portion of 244e290 amino acids
(aa) and a C-terminal portion of 338e364 aa, have been
demonstrated to be key regions for association with the P
protein, based on a bovine RSV MG assay.5
The P protein itself is essential for viral RNA synthesis. In
the case of the Paramyxoviridae family, the P protein is an
intrinsically disordered polypeptide, which forms tetramers
through a central a-helical coiled-coil region and is regar-
ded as being responsible for the recruitment of the large
polymerase L onto the viral N-RNA template through direct
interactions with N and L.21 Using a human parainfluenza
virus type 3 (hPIV3) MG system, it was confirmed that the N
terminal of hPIV3 P protein is primarily involved in viral
replication, whereas the C terminal is involved in both
transcription and replication.22 Based on an RSV MG assay,
two P protein regions, an internal 161e180 aa and a C
terminal 221e241 aa, have been shown to be independent
N protein-binding sites, and residues 121e160 were shown
to be the L protein-binding site.23 Furthermore, the effect
of P protein on viral replication and translation occurs
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P protein associates with the N protein for viral RNA
encapsidation, and with the L protein for transcriptional
activity.
The L protein is the largest and least abundant of the
structural proteins, and is considered to be the viral poly-
merase, probably due to its location to transcriptionally
active viral cores. It is thought that L protein performs
multiple functions, including RNA synthesis, capping, and
methylation, as well as polyadenylation.24,25 Measles virus
(MV) and canine distemper virus (CDV) MG constructs have
been used for investigating heterologous N, P, and L protein
combinations. The results of such studies revealed that
there is no heterologous restriction in either MG replication
assay.4 Some heterologous helper plasmids actually
generate a higher level of reporter gene product than that
of their homologous counterparts. Sequencing indicated
that MV N, P, and L proteins may have the same motifs as
CDV N, P, and L proteins, respectively. The cis-acting signal
of MV and CDV may also be similar in part in both UTRs.
However, this has not been experimentally verified.
Conceivably, the broader specificity of the L protein is in
part due to a variation in the polymerases of vaccine and
wild-type strains of morbilliviruses.26 It has been estab-
lished that, phenotypically, MV polymerases from vaccine
strains have greater transcriptional processing capacity
than their wild-type equivalents,27 a fact that may
contribute to their overall attenuated phenotype. A peste
des petits ruminants virus (PPRV) MG was constructed to
confirm the function of L protein, and three domains (A, B,
and C) of the L protein were predicted from multiple
sequence alignments.28 These three domains could interact
with N protein, P protein, and genomic RNA, respectively.
The M protein is the most abundant protein in the virion
and is peripherally associated with the viral membrane.29,30
In MV MG assays,31 M protein has been verified as being a
regulator of viral RNA synthesis and assembly through
interaction with N protein; MG RNA synthesis is inhibited by
interaction between M protein and C-terminal residues of
the N protein. These results indicated that the M and C
proteins regulate viral RNA synthesis by different means. By
contrast, MV M protein could not affect the efficiency of
reporter gene expression in SeV and PIV5 MG assays.31 The
interaction between N and M proteins is probably specific to
each virus of the family; however, to our knowledge, it is
not yet known which domain(s) are involved in the MeN
protein interaction. Although M protein plays an important
role in regulating the rate of viral replication, protein
synthesis, and viral assembly, it remains unclear whether
the M protein of all members of the Paramyxoviridae family
and other virus families possesses the same regulatory
function. In a previous study using an RSV MG system,32
coexpression of the M2 gene at high levels of input
plasmid inhibited transcription and replication, but resul-
ted in efficient production of full-length RNAs at a high
level, especially for genes larger than approximately 1000
nt. These findings suggested that the amount of RSV M2
protein could have a very important effect on the balance
between RNA transcription and replication. Furthermore, it
was shown that RNA and P binding to RSV protein M2-1 can
be uncoupled, and that both are critical for the transcrip-
tional antitermination function of M2-1.33In short, an MG system could possibly be established for
each virus, and then various studies could be conducted to
research viral replication and transcription. More impor-
tant, virus-free technologies that would not pose biosafety
issues could be developed. In addition, the MG technology
has been approved as a promising tool for research of
protein interactions and associations within the RNP or
RdRp complex. Using an MG assay together with other
experimental approaches, much information has been
accumulated in terms of the function and structure of viral
proteins. However, MG technology could not be directly
applied to studies of the envelop glycoprotein or attach-
ment protein of the family, as these are not components of
the RNP or RdRp complex.
Nonstructural proteins
Nonstructural proteins are proteins encoded by viral genes,
but which do not form part of the viral particle. The C, V,
and W proteins are known nonstructural proteins of many
Paramyxoviridae viruses and play multiple roles in the viral
life cycle. The V protein of most viruses in the Para-
myxoviridae family is known to bind to intracellular mela-
noma differentiation-associated gene 5, which is an
interferon (IFN)-inducible box helicase, and therefore in-
terrupts the signal transduction pathway activating the IFN-
b promoter by forming double-stranded RNA.34 In an MV MG
assay, mutations in the V protein caused proteineRNA
binding to occur again, and therefore, to function as a
template for RNA synthesis.35 Furthermore, MV C, V, and W
proteins inhibited Nipah virus (NiV) MG RNA replication; NiV
C and V proteins inhibited MV MG RNA replication.6 How-
ever, the mechanisms by which MV V and C proteins inhibit
their own and NiV MG RNA replication are poorly under-
stood. By contrast, sequencing indicated that MV C and V
proteins may have a close relationship with NiV C and V
proteins, respectively, with respect to their roles in viral
replication. The hRSV MG experiment was performed, and
revealed that nonstructural protein NS1 can inhibit RNA
transcription and replication and that it functions as a
negative regulator in the viral life cycle.36 These studies
collectively illustrated that one of the roles of these
nonstructural proteins is to regulate viral RNA synthesis,
although the mechanism is not fully clear. These experi-
mental findings further showed that MG technology is a
useful tool for exploring the roles of nonstructural proteins
of this virus family at the level of transcription and repli-
cation. The domain locations or functional amino acid sites
of those nonstructural proteins related to the virus life
cycle could be further mapped using the MG platform.
Viral noncoding regions
The MG system is a powerful biotechnology tool for investi-
gating noncoding regions of the viral genome that function as
viral cis-acting signals or indeed other regulatory roles
involved in the virus life cycle. In an experiment using a
Newcastle disease virus (NDV) MG, the reporter activity in
cells transfected with a single helper plasmid, expressing L
protein, was higher than that of the blank and negative con-
trols, as a result of a possibly unknown eukaryotic promoter-
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Postulated vaccine-related changes at Positions 5 and 26 in
the rinderpest virus (RPV) genomepromoter (GP)mayaccount
for the inability of PPRV helper proteins to recognize and
interact efficiently with RPV GP.37 A mutation from A to G at
the 7th positionwas shown to inhibit accumulation of RSVanti-
MG RNA, but did not inhibit mRNA synthesis in an RSV MG
assay.38 This finding indicated that the 7th position plays key
roles in the genome and anti-GP sequences. As in other non-
segmented negative-strand RNA viruses, although RSV inter-
genic regions also function to separate the viral genome into
nine genes, these regions do not modulate the efficiency of
subsequent transcription in the dicistronic MG system.39 This
supported the idea that the various intergenic regions do not
affect the efficiency of recognition of adjacent, upstream
gene-end signals and do not affect the levels of read-through
mRNAs produced by the polymerase. Furthermore, combining
selective 20-hydroxyl acylation analyzed by primer extension
(SHAPE), antisense-interfered SHAPE, and Pb2þ-induced
cleavage analysis with a dengue virus MG RNA assay not only
verified long-range interactions between the 50- and 30-ter-
minal regions, which involved hybridization during 50e30
cyclization, the 50e30 upstream of AUG region as well as 50e30
downstream of AUG region, but also revealed that communi-
cation between the 50e30-terminal regions strongly depends
on the structure and sequence composition of the 50-cycliza-
tion region.40 Structure-directed and site-directed mutagen-
esis analyses of viral MG RNA are novel approaches for
elucidating viral RNA replication and synthesis.A tool for high-throughput screening of potential
antiviral compounds
Screening antiviral drugs using infected cell models require
a laboratory with a high biosafety level. However, virus-
free MG systems have been widely used for screening
antiviral drugs. To date, large numbers of compounds have
been tested for potential antiviral activity using an MG
platform. In brief, after development, characterization,
and optimization, MG-transfected cells are treated with
potential antiviral compounds for a limited period and are
then assayed for reporter gene activity.8 Six of 960 com-
pounds were found to inhibit luciferase activity by >70% in
an Ebola virus MG reporter system.41 However, it is impor-
tant to keep in mind that antiviral drugs screened by MG
assay would not inhibit other stages of the virus life cycle.
Therefore, the viral and cellular proteins/pathway targets
of those compounds will require further investigation.
Although rescuing newly recombinant viruses from a full-
length cDNA clone has provided important advantages in the
development of vaccines, vectors, and the study of viral gene
function, it raises new concerns that the recombinant virus
could be pathogenic to humans and animals. By contrast,
direct studies of wild-type viruses are cumbersome. In such
cases, these agents, classified under biosafety level 3 or 4,
regardless of whether they represent the original virus or a
new recombinant virus, constitute a threat to human and
animal safety, and may even be bioterror agents.
The MG methods have several attractive advantages,
compared with traditional experimental approaches. An MG
system does not only avoid the threats posed by a live virusto laboratory workers and the environment, but also facil-
itates study of the molecular biology of the virus, whether
or not it has been rescued from full-length cDNA clones.26,42
Furthermore, prior to rescuing a recombinant virus from its
full-length cDNA, an MG system is first useful to verify the
validity of the experimental process.43 Moreover, recom-
binant MG RNA can be packaged into virus-like particles;
these pseudotype viruses containing a foreign gene could
be passaged several times in the cells.44 Therefore, an MG
system could be a multifunctional platform for the research
of viruses, as previously reviewed.45 In addition to the
Paramyxoviridae family, MG technology has also been used
to study other virus families, including viruses from the
Rhabdoviridae,46 Filoviridae,20 Bornaviridae47 families, and
other minus- or even plus-stranded RNA viruses, such as the
hepatitis C virus.48 Furthermore, MG technology revolu-
tionized the approaches to screen candidate compounds
against viruses, without requiring infectious viruses, and
also facilitated detection of neutralizing antibodies.
Another potential use of the MG system is in the study of
gene products of nonviral origin, such as cytokines, cyto-
kine antagonists, or other immune modifiers, on the virus.
In contrast to immunoprecipitation, Western blot analyses,
yeast two-hybrid assays, among others, MG technology
could allow interaction of more than two proteins in a dy-
namic system, and the downstream reaction could also be
observed by detection of expression of targeted proteins or
mRNAs.4,27 Moreover, a recent study that combined MG
technology with crystallization and structure determination
assays identified more than 3 aa residues in influenza A
virus N proteins that are critical for N protein dimer for-
mation, which is required for viral RNA replication.49
Therefore, the MG system as a model of viral replication
has its own unique features and represents a breakthrough
in the in vitro research of viral replication and transcrip-
tion, and of antiviral drugs, etc.
Despite the wide use of the MG system, there are still
many limitations to this approach. Because of a lack of viral
proteins in trans, MG can also not be used to study viral
primary transcription. The intracellular environment for
the plasmid-based expression of helper proteins is very
different from the normal infectious cycle in terms of the
stoichiometry of the helper proteins present in the system.
Furthermore, a viral MG is considerably shorter than its full-
length genome. These limitations should be considered
when planning an MG assay.
As our understanding in MG technology and the virus life
cycle deepens, there will be new opportunities for the
development of antiviral agents that specifically target
pathways associated with viral replication, transcription,
and translation, such as successful antiretroviral protease
inhibitors.Conflicts of interest
All contributing authors declare no conflicts of interest.Acknowledgments
We thank Dr Qiuwei Pan for proofreading this paper.
128 J. Su et al.References
1. Galinski MS. Paramyxoviridae: transcription and replication.
Adv Virus Res 1991;39:129e62.
2. Pomeroy LW, Bjørnstad ON, Holmes EC. The evolutionary and
epidemiological dynamics of the paramyxoviridae. J Mol Evol
2008;66:98e106.
3. Ben Abdeljelil N, Delmas B, Mardassi H. Replication and
packaging of an infectious bursal disease virus segment A-
derived minigenome. Virus Res 2008;136:146e51.
4. Brown DD, Collins FM, Duprex WP, Baron MD, Barrett T,
Rima BK. ‘Rescue’ of mini-genomic constructs and viruses by
combinations of morbillivirus N, P and L proteins. J Gen Virol
2005;86:1077e81.
5. Khattar SK, Yunus AS, Collins PL, Samal SK. Mutational analysis
of the bovine respiratory syncytial virus nucleocapsid protein
using a minigenome system: mutations that affect encapsida-
tion, RNA synthesis, and interaction with the phosphoprotein.
Virology 2000;270:215e28.
6. Sleeman K, Bankamp B, Hummel KB, Lo MK, Bellini WJ,
Rota PA. The C, V and W proteins of Nipah virus inhibit mini-
genome replication. J Gen Virol 2008;89:1300e8.
7. Feng H, Wei D, Nan G, Cui SJ, Chen ZN, Bian H. Construction of
a minigenome rescue system for Newcastle disease virus strain
Italien. Arch Virol 2011;156:611e6.
8. Freiberg A, Dolores LK, Enterlein S, Flick R. Establishment and
characterization of plasmid-driven minigenome rescue systems
for Nipah virus: RNA polymerase I- and T7-catalyzed generation
of functional paramyxoviral RNA. Virology 2008;370:33e44.
9. Li BY, Li XR, Lan X, Yin XP, Li ZY, Yang B, et al. Rescue of
Newcastle disease virus from cloned cDNA using an RNA poly-
merase II promoter. Arch Virol 2011;156:979e86.
10. Wadkins TS, Been MD. Ribozyme activity in the genomic and
antigenomic RNA strands of hepatitis delta virus. Cell Mol Life
Sci 2002;59:112e25.
11. Fuerst TR, Niles EG, Studier FW, Moss B. Eukaryotic transient-
expression system based on recombinant vaccinia virus that
synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad
Sci USA 1986;83:8122e6.
12. Fix J, Galloux M, Blondot ML, Ele´oue¨t JF. The insertion of
fluorescent proteins in a variable region of respiratory syncy-
tial virus L polymerase results in fluorescent and functional
enzymes but with reduced activities. Open Virol J 2011;5:
103e8.
13. Wei GC, Tian WH, Wang G, Liu YF, Yu CJ, Dong XY, et al.
Comparison of the rescue efficiency of Sendai virus mini-
genome mediated by CMV and T7 promoter. Bing Du Xue Bao
2012;28:237e45 [Article in Chinese].
14. Walpita P, Flick R. Reverse genetics of negative-stranded RNA
viruses: a global perspective. FEMS Microbiol Lett 2005;244:
9e18.
15. Song MS, Baek YH, Pascua PN, Kwon HI, Park SJ, Kim EH, et al.
Establishment of Vero cell RNA polymerase I-driven reverse
genetics for influenza A virus and its application for pandemic
(H1N1) 2009 influenza virus vaccine production. J Gen Virol
2013;94:1230e5.
16. Li C, Huang J, Li Y, He F, Li D, Sun Y, et al. Efficient and stable
rescue of classical swine fever virus from cloned cDNA using an
RNA polymerase II system. Arch Virol 2013;158:901e7.
17. Flick K, Hooper JW, Schmaljohn CS, Pettersson RF,
Feldmann H, Flick R. Rescue of Hantaan virus minigenomes.
Virology 2003;306:219e24.
18. Halpin K, Bankamp B, Harcourt BH, Bellini WJ, Rota PA. Nipah
virus conforms to the rule of six in a minigenome replication
assay. J Gen Virol 2004;85:701e7.
19. Fearns R, Peeples ME, Collins PL. Increased expression of the N
protein of respiratory syncytial virus stimulates minigenomereplication but does not alter the balance between the syn-
thesis of mRNA and antigenome. Virology 1997;236:188e201.
20. Mu¨hlberger E, Weik M, Volchkov VE, Klenk HD, Becker S.
Comparison of the transcription and replication strategies of
Marburg virus and Ebola virus by using artificial replication
systems. J Virol 1999;73:2333e42.
21. Leyrat C, Renner M, Harlos K, Grimes JM. Solution and crys-
tallographic structures of the central region of the phospho-
protein from human metapneumovirus. PLoS One 2013;8.
e80371.
22. De BP, Hoffman MA, Choudhary S, Huntley CC, Banerjee AK.
Role of NH2- and COOH-terminal domains of the P protein of
human parainfluenza virus type 3 in transcription and replica-
tion. J Virol 2000;74:5886e95.
23. Khattar SK, Yunus AS, Samal SK. Mapping the domains on the
phosphoprotein of bovine respiratory syncytial virus required
for N-P and P-L interactions using a minigenome system. J Gen
Virol 2001;82:775e9.
24. Poch O, Blumberg BM, Bougueleret L, Tordo N. Sequence
comparison of five polymerases (L proteins) of unsegmented
negative-strand RNA viruses: theoretical assignment of func-
tional domains. J Gen Virol 1990;71:1153e62.
25. Stec DS, Hill 3rd MG, Collins PL. Sequence analysis of the po-
lymerase L gene of human respiratory syncytial virus and pre-
dicted phylogeny of nonsegmented negative-strand viruses.
Virology 1991;183:273e87.
26. Bailey D, Chard LS, Dash P, Barrett T, Banyard AC. Reverse
genetics for peste-des-petits-ruminants virus (PPRV): promoter
and protein specificities. Virus Res 2007;126:250e5.
27. Bankamp B, Kearney SP, Liu X, Bellini WJ, Rota PA. Activity of
polymerase proteins of vaccine and wild-type measles virus
strains in a minigenome replication assay. J Virol 2002;76:
7073e81.
28. Minet C, Yami M, Egzabhier B, Gil P, Tangy F, Bre´mont M, et al.
Sequence analysis of the large (L) polymerase gene and trailer
of the peste des petits ruminants virus vaccine strain Nigeria
75/1: expression and use of the L protein in reverse genetics.
Virus Res 2009;145:9e17.
29. Faaberg KS, Peeples ME. Association of soluble matrix protein
of Newcastle disease virus with liposomes is independent of
ionic conditions. Virology 1988;166:123e32.
30. Sanderson CM, McQueen NL, Nayak DP. Sendai virus assembly:
M protein binds to viral glycoproteins in transit through the
secretory pathway. J Virol 1993;67:651e63.
31. Iwasaki M, Takeda M, Shirogane Y, Nakatsu Y, Nakamura T,
Yanagi Y. The matrix protein of measles virus regulates viral
RNA synthesis and assembly by interacting with the nucleo-
capsid protein. J Virol 2009;83:10374e83.
32. Olivo PD, Collins PL, Peeples ME, Schlesinger S. Detection and
quantitation of human respiratory syncytial virus (RSV) using
minigenome cDNA and a Sindbis virus replicon: a prototype
assay for negative-strand RNA viruses. Virology 1998;251:
198e205.
33. Blondot ML, Dubosclard V, Fix J, Lassoued S, Aumont-Nicaise M,
Bontems F, et al. Structure and functional analysis of the RNA-
and viral phosphoprotein-binding domain of respiratory syn-
cytial virus M2-1 protein. PLoS Pathog 2012;8. e1002734.
34. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N,
Goodbourn S, et al. The V proteins of paramyxoviruses bind the
IFN-inducible RNA helicase, mda-5, and inhibit its activation of
the IFN-beta promoter. Proc Natl Acad Sci USA 2004;101:
17264e9.
35. Parks CL, Witko SE, Kotash C, Lin SL, Sidhu MS, Udem SA. Role
of V protein RNA binding in inhibition of measles virus mini-
genome replication. Virology 2006;348:96e106.
36. Atreya PL, Peeples ME, Collins PL. The NS1 protein of human
respiratory syncytial virus is a potent inhibitor of minigenome
transcription and RNA replication. J Virol 1998;72:1452e61.
Minigenome technology 12937. Mioulet V, Barrett T, Baron MD. Scanning mutagenesis identifies
critical residues in the rinderpest virus genome promoter. J
Gen Virol 2001;82:2905e11.
38. Peeples ME, Collins PL. Mutations in the 50 trailer region of a
respiratory syncytial virus minigenome which limit RNA repli-
cation to one step. J Virol 2000;74:146e55.
39. Kuo L, Fearns R, Collins PL. The structurally diverse intergenic
regions of respiratory syncytial virus do not modulate
sequential transcription by a dicistronic minigenome. J Virol
1996;70:6143e50.
40. Sztuba-Solinska J, Teramoto T, Rausch JW, Shapiro BA,
Padmanabhan R, Le Grice SF. Structural complexity of dengue
virus untranslated regions: cis-acting RNA motifs and pseu-
doknot interactions modulating functionality of the viral
genome. Nucleic Acids Res 2013;41:5075e89.
41. Jasenosky LD, Neumann G, Kawaoka Y. Minigenome-based re-
porter system suitable for high-throughput screening of com-
pounds able to inhibit Ebolavirus replication and/or
transcription. Antimicrob Agents Chemother 2010;54:3007e10.
42. Poh LY, Zamrod Z, Rabu A. Effects of point mutations at posi-
tions 79, 85 and 91 of the Nipah virus leader sequence to its
minigenome expression. Sains Malays 2011;40:1139e46.
43. Lee KJ, Novella IS, Teng MN, Oldstone MBA, de La Torre JC. NP
and L proteins of lymphocytic choriomeningitis virus (LCMV)
are sufficient for efficient transcription and replication of
LCMV genomic RNA analogs. J Virol 2000;74:3470e7.44. Mu¨hlberger E, Lo¨tfering B, Klenk HD, Becker S. Three of the
four nucleocapsid proteins of Marburg virus, NP, VP35, and L,
are sufficient to mediate replication and transcription of
Marburg virus-specific monocistronic minigenomes. J Virol
1998;72:8756e64.
45. Hoenen T, Groseth A, de Kok-Mercado F, Kuhn JH, Wahl-
Jensen V. Minigenomes, transcription and replication compe-
tent virus-like particles and beyond: reverse genetics systems
for filoviruses and other negative stranded hemorrhagic fever
viruses. Antiviral Res 2011;91:195e208.
46. Biacchesi S, Yu YX, Be´arzotti M, Tafalla C, Fernandez-Alonso M,
Bre´mont M. Rescue of synthetic salmonid rhabdovirus mini-
genomes. J Gen Virol 2000;81:1941e5.
47. Rosario D, Perez M, de la Torre JC. Functional characterization
of the genomic promoter of borna disease virus (BDV): impli-
cations of 30-terminal sequence heterogeneity for BDV persis-
tence. J Virol 2005;79:6544e50.
48. Chen L, Zhang S, Banerjee AK, Chen M. N-terminal phosphor-
ylation of phosphoprotein of vesicular stomatitis virus is
required for preventing nucleoprotein from binding to cellular
RNAs and for functional template formation. J Virol 2013;87:
3177e86.
49. Ye Q, Guu TS, Mata DA, Kuo RL, Smith B, Krug RM, et al.
Biochemical and structural evidence in support of a coherent
model for the formation of the double-helical influenza A virus
ribonucleoprotein. MBio 2012;4. e00467e12.
